// App-Quantinova.ai

e13502 : Outcome and follow-up of glioblastoma patients treated with bevacizumab based therapy in 2nd lign treatment.

Researchers

Presenter

  • Benjamin Auberger

Principal Investigators

  • Marie Robert

  • Friederike Schlurmann

  • Laura Deiana

  • Isabelle Quintin-Roue

  • Helene Simon

  • Petra Miglierini

  • Mario Campone

  • Phong Dam-Hieu

  • Jean-Sebastien Frenel

  • Elsa Magro

  • Carole Gourmelon

  • Jerome Martin-Babau

Medical Centers

  • Medical Oncology, C.H.U Augustin Morvan - Brest University Hospital, Brest, France

  • Cancer Institute of the West (ICO), Nantes, France

  • Pathology, Brest, France

  • Medical Oncology, C.H.U Augustin Morvan - Brest University Hospital, Brest, France

  • Cancer Institute of the West (ICO), Centre Rene Gauducheau, Medical Oncology Department, Saint-Herblain, France

  • NeuroSurgery, Brest, France

  • Institut de Cancerologie de l'Ouestsite Rene Gauducheau, Saint Herblain, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Bevacizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved